The estimated Net Worth of Charles Lickfold is at least $691 ezer dollars as of 23 August 2023. Mr. Lickfold owns over 190 units of Catalent stock worth over $676,145 and over the last few years he sold CTLT stock worth over $14,963. In addition, he makes $0 as Senior Vice President és Chief Information Officer at Catalent.
Charles has made over 2 trades of the Catalent stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 190 units of CTLT stock worth $8,497 on 23 August 2023.
The largest trade he's ever made was selling 190 units of Catalent stock on 23 August 2023 worth over $8,497. On average, Charles trades about 163 units every 11 days since 2023. As of 23 August 2023 he still owns at least 11,339 units of Catalent stock.
You can see the complete history of Mr. Lickfold stock trades at the bottom of the page.
Charles Lickfold serves as Senior Vice President, Chief Information Officer of the Company. With more than 20 years of experience in digital and information technology, Mr. Lickfold has demonstrated significant IT leadership in the pharmaceutical services industry throughout his career. Prior to joining Catalent, he held numerous leadership positions, including Chief Information Officer at Alcami, Avara Pharmaceutical Services, and Gilbarco Veeder-Root. He also served as Vice President and Head of IT for Patheon. His depth of experience in both applications and infrastructure across diverse IT environments includes extensive work in the areas of IT transformation, corporate mergers and acquisitions, and business change programs. Mr. Lickfold began his career as a management consultant in the life sciences practice of Ernst & Young LLP after earning his bachelor's degree in computer science from the University of Kentucky's College of Engineering.
Charles's mailing address filed with the SEC is C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET, NJ, 08873.
Over the last 10 years, insiders at Catalent have traded over $2,686,980,380 worth of Catalent stock and bought 123,000 units worth $5,376,345 . The most active insiders traders include Management Associates V L.L..., Peter Zippelius és Frank A Damelio. On average, Catalent executives and independent directors trade stock every 17 days with the average trade being worth of $22,866,018. The most recent stock trade was executed by Ricky Hopson on 2 August 2024, trading 662 units of CTLT stock currently worth $39,429.
catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p
Catalent executives and other stock owners filed with the SEC include: